about
Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analoguesIn vivo growth-inhibition of Sarcoma 180 by an alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill.Cytotoxic potential of selected medicinal plants in northeast Brazil.Overview of the Role of Vanillin on Redox Status and Cancer Development.Anti-liver cancer activity in vitro and in vivo induced by 2-pyridyl 2,3-thiazole derivatives.Pyranochromones from Dictyoloma vandellianum A. Juss and Their Cytotoxic Evaluation.In vivo antitumor effect, induction of apoptosis and safety of Remirea maritima Aubl. (Cyperaceae) extracts.Chemical Composition of the Essential Oil from the Fresh Fruits of Xylopia laevigata and its Cytotoxic Evaluation.Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations.Antitumour Activity of the Microencapsulation of Annona vepretorum Essential Oil.Antitumor Properties of the Essential Oil From the Leaves of Duguetia gardneriana.Antitumour efficacy of Piper tuberculatum and piplartine based on the hollow fiber assay.ent-Kaurane diterpenes from the stem bark of Annona vepretorum (Annonaceae) and cytotoxic evaluation.Eudesmol isomers induce caspase-mediated apoptosis in human hepatocellular carcinoma HepG2 cells.Antitumour properties of the leaf essential oil of Xylopia frutescens Aubl. (Annonaceae).Cytotoxic effect of leaf essential oil of Lippia gracilis Schauer (Verbenaceae).Chemical constituents and anticancer effects of the essential oil from leaves of Xylopia laevigata.Evaluation of the cytotoxic activity of some Brazilian medicinal plants.In vitro and in vivo antitumor effects of the essential oil from the leaves of Guatteria friesiana.The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.Cytotoxic Alkaloids from the Stem of Xylopia laevigata.In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone.7,7-Dimethylaporphine and Other Alkaloids from the Bark of Guatteria friesiana.In vivo growth inhibition of sarcoma 180 by latex proteins from Calotropis procera.Oxidative stress induction by (+)-cordiaquinone J triggers both mitochondria-dependent apoptosis and necrosis in leukemia cells.Synthesis and cytotoxic activity of alpha-santonin derivatives.Antitumor properties of a sulfated polysaccharide from the red seaweed Champia feldmannii (Diaz-Pifferer).Evaluation of the genotoxicity of piplartine, an alkamide of Piper tuberculatum, in yeast and mammalian V79 cells.In vivo growth inhibition of sarcoma 180 by piperlonguminine, an alkaloid amide from the Piper species.Synthesis and cytotoxic activity of some 3-benzyl-5-arylidenefuran-2(5H)-ones.Melipona mondury produces a geopropolis with antioxidant, antibacterial and antiproliferative activities.Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways.Encapsulation of carvacrol, a monoterpene present in the essential oil of oregano, with β-cyclodextrin, improves the pharmacological response on cancer pain experimental protocols.Larvicidal and nematicidal activities of the leaf essential oil of Croton regelianus.Kauren-19-oic acid induces DNA damage followed by apoptosis in human leukemia cells.Piplartine induces genotoxicity in eukaryotic but not in prokaryotic model systems.Antitumor activity of two derivatives from 2-acylamine-1, 4-naphthoquinone in mice bearing S180 tumor.Antiproliferative effects of two amides, piperine and piplartine, from Piper species.Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.The Dual Antioxidant/Prooxidant Effect of Eugenol and Its Action in Cancer Development and Treatment.
P50
Q28540656-6AFCDA5F-1B88-4B5B-A055-9B460A01E1E6Q34013517-F16B42FF-100F-44B9-89D8-4A17F2AB3176Q36071328-B2E7A6D8-5EDE-4825-BC26-72332879DA78Q37548149-BC95AB1F-3ECA-4E91-9395-891092228F35Q38700429-085D5488-8F51-48EE-A2C5-97309F197612Q38734986-C7B9CB63-F2EB-41EA-9F42-27800562991FQ38759348-0A101643-936C-47BE-A722-4A6B5CC640CEQ38771670-0F3007A4-7836-4050-8A32-AAD4F4C75E7DQ38779214-3A1CA6D7-9319-479C-8D1A-4711283C50C3Q38837049-DB27C999-0B1D-41C9-BF0B-F339ED237618Q38858539-E7DE368E-2C30-42F9-896E-EDB60F9BDE1FQ38927577-C3168C2D-FF32-4971-B7A9-288B4E594631Q38980895-B7EDFBFC-F70B-4407-8C75-7654B48481DBQ39137230-06758A66-0A90-46D7-A133-45EA3D0E99B3Q39139553-C7713DF8-5A0A-4434-8AE9-FE4C32A9C593Q39186687-30E530DB-6436-4205-ABEB-F8FE69290B7CQ39212640-6EA5B9F6-D067-4151-AF76-CDF69E41D297Q39311561-59DD35CE-5BB6-4B65-8AAF-45D4E74CDA70Q39406878-C21B065E-65D8-4E42-A6B5-90AFB0E766FDQ39586878-B785EC97-E232-427D-921F-A04E904955CDQ39614481-ECE0448D-398A-47C4-862B-E9E24379ACE2Q39658811-3E00AD34-6769-4560-88FB-AD591ADFA32DQ39684485-DC4445E9-B91B-499C-A064-4BC38425368BQ39697607-562EE3B6-3278-43FE-8451-B45C5E64E718Q39766692-65D1C274-FD32-478F-A957-7DA17A4C2325Q39858323-65F5424A-9951-4710-A95D-C3938EE45E25Q39957816-4B1EB466-4B65-4C9B-824F-D81D6C4DCA17Q39997631-4943CDF4-9FB0-4432-AD3D-B2B771017E96Q40058858-085FD38E-DE4B-40DC-B649-DBFE7BB5FDD4Q40079798-A6B96F6A-6E58-4993-A5E1-7EE9A3D9DA21Q40118760-FDB85D6F-6C4D-42A9-8CF5-C2357D63D727Q40232439-9AB64689-5E08-4E35-B598-FACBF50CBED4Q42702994-8775A8E9-0858-42AB-8512-5256D9F7FBBEQ42983954-2B3C7F53-7C7D-4B27-A9C9-1A3D15EF1250Q46038223-CC6353F9-7AE4-4FEA-9A9B-2899D022F9B3Q46044099-F1B15449-919C-4031-8E62-012C1C9E7025Q46204130-6529F622-4334-44DF-8E03-570396211A05Q46704191-0FE17D49-35F7-480A-8FB3-F06C56C2427CQ47128819-CD634F5D-CD8B-4707-AD41-1B47CA356A85Q47164050-D06C47A1-0743-4336-90F5-8CE90B88F44E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel P. Bezerra
@ast
Daniel P. Bezerra
@en
Daniel P. Bezerra
@es
Daniel P. Bezerra
@nl
Daniel P. Bezerra
@sl
type
label
Daniel P. Bezerra
@ast
Daniel P. Bezerra
@en
Daniel P. Bezerra
@es
Daniel P. Bezerra
@nl
Daniel P. Bezerra
@sl
prefLabel
Daniel P. Bezerra
@ast
Daniel P. Bezerra
@en
Daniel P. Bezerra
@es
Daniel P. Bezerra
@nl
Daniel P. Bezerra
@sl
P1053
K-7889-2017
P106
P1153
22980790800
8662392800
P21
P31
P3829
P496
0000-0002-6774-2063